Therapeutic Strategies for Patient Safety

Therapeutic Strategies for Patient Safety represents, regardless of the medical field in which it is developed, a way of approaching that can lead to reducing the risks of applying therapies, developing patient-oriented therapeutic plans, based on the promotion of positive results, but also on the development of personalized medicine, applicable and adaptable to each patient. The literature is typically focused on therapeutic strategies or patient safety, but fewer approaches focus on promoting patient safety and implementing a plan to prevent harm.

The development of therapeutic strategies that prioritize patient safety requires the advancement of specific research and the creation of reliable therapeutic tools and measures, which are essential for the strategy to be effective, grounded in moral principles, and in accordance with established ethical standards.

The understanding of the phenomenon of the development of Therapeutic Strategies for Patient Safety was achieved both based on 5 literature searches in PubMed, MEDLINE, Plus, Scopus, and Web of Science (2015-2023) and through the development of articles (review or original), from different medical fields, by doctoral students (first author) and their teams, and which are part of a special issue of the American Journal of Therapeutics, entitled "Therapeutic strategies for patient safety."

Patient safety and therapeutic strategies are regulated by laws and regulations at the EU level and are a concern for those developing research in the field of clinical medicine. The articles that are part of the special issue of the AJT each represent a model for the development of research in the field of patient safety, regardless of the field of medical (polypharmacy, vancomycin therapy) or surgical (urolithiasis, rectal cancer) therapy, of the use of conventional or nonconventional instruments (remote monitoring devices, telemedicine, transcranial direct current stimulation), through care organized within medical institutions or through self-care (effective self-care among newly diagnosed patients), regardless of the stage or severity of the condition (end-of-life care, management of organophosphate poisoning).

The development of a health system based on moral and ethical values and oriented toward increasing the quality of life through therapeutic strategies and measures to ensure patient safety, a holistic approach to the patient and the disease, and the development of personalized therapies contribute to increasing the efficiency of medical activity and improving clinical outcomes in conditions of reduced risks and errors in health systems.